MICRONIT GMBH

Their core work

Micronit is a German SME specializing in the design and manufacture of microfluidic chips and lab-on-chip devices, using precision microfabrication techniques in glass and silicon. Their real-world value lies in translating laboratory analytical processes into miniaturized, manufacturable components — reducing cost and size without sacrificing analytical performance. In NanoPilot they contributed micro-manufacturing process expertise to a GMP-compliant nanopharmaceutical pilot line, and in PICOGC they developed a miniaturized gas chromatograph aimed at cost-effective field deployment. They occupy the niche between academic microfluidics research and industrial-scale production of precision analytical components.

What they specialise in

How they've shifted over time

Both projects ran concurrently (2015-2020), so there is limited sequential evolution to trace, and keyword metadata is absent from both records. What the project types do reveal is a parallel strategy: NanoPilot positioned Micronit as a manufacturing process partner within a larger R&D consortium (RIA scheme), while PICOGC positioned them as the commercial lead developing their own product under the SME Instrument — a scheme designed for market-ready innovations. This suggests the organization was simultaneously deepening manufacturing R&D partnerships and pushing its own product lines toward commercialization during the same period.

Micronit appears to be moving from being a component supplier within research consortia toward owning the full product and commercialization pathway for its miniaturized analytical instruments.

How they like to work

Micronit has never led an H2020 project as coordinator — they consistently join as specialist partners, contributing a defined technical capability (chip fabrication, miniaturization) rather than orchestrating the project. With 11 unique partners across only 2 projects, their consortia were reasonably sized and diverse. This profile suggests they are an effective technology plug-in partner: clear deliverable, defined scope, low coordination overhead for the project lead.

Micronit has worked with 11 distinct partners across 8 countries in just two projects, indicating a deliberately diverse network for a small SME. Their reach spans multiple European countries, consistent with their positioning in pan-European nanotechnology and instrumentation consortia.

What sets them apart

Micronit fills a gap that pure research groups and large industrial players both struggle with: they can fabricate precision microfluidic chips at a quality and scale that bridges prototype and production. As an SME, they are agile enough for bespoke consortium work, yet experienced enough to deliver GMP-adjacent manufacturing and commercially viable products. For consortium builders, they bring both a technical asset (chip fabrication) and commercial credibility (SME Instrument Phase 2 recipient).

Highlights from their portfolio

• PICOGC
  Funded under the competitive SME Instrument Phase 2 scheme, indicating the micro-GC was judged market-ready by EU evaluators — a strong signal of product maturity and commercial potential.
• NanoPilot
  Demonstrates Micronit's ability to contribute to GMP-compliant pharmaceutical manufacturing processes, expanding their relevance beyond pure analytics into regulated life sciences production.